Voyager Therapeutics (VYGR) Short-term Investments (2015 - 2026)

Voyager Therapeutics (VYGR) has 12 years of Short-term Investments data on file, last reported at $98.2 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 39.13% year-over-year to $98.2 million; the trailing twelve-month figure through Mar 2026 stood at $98.2 million (down 39.13% YoY), and the FY2025 full-year result was $131.1 million, down 32.85% from the prior year.
• Short-term Investments fell to $98.2 million in Q1 2026, from $131.1 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $294.9 million in Q2 2024 to a low of $5.0 million in Q1 2023.
• A 5-year average of $132.2 million and a median of $161.3 million in 2025 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments plunged 85.72% in 2023 and soared 5036.99% in 2024, its largest moves.
• Tracing VYGR's Short-term Investments over 5 years: stood at $19.9 million in 2022, then surged by 714.89% to $162.1 million in 2023, then grew by 20.51% to $195.3 million in 2024, then slumped by 32.85% to $131.1 million in 2025, then decreased by 25.15% to $98.2 million in 2026.
• Business Quant data shows VYGR's Short-term Investments at $98.2 million in Q1 2026, $131.1 million in Q4 2025, and $163.8 million in Q3 2025.